rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Eran Broshy

Director and Other role

Company insider

Files Form 4 as: Director and Other, Certara; Director, Theravance Biopharma; Director, Magellan Health; Executive Chairman, Inventiv Health; Director, Neurogen.

Every Form 4 they filed

In numbers

Trades disclosed
135
Buys
4
Sells
14
Bought
$905K
Sold
$11.5M
Companies
5
Companies where not an officer
4
First trade
17 Jan 2006
Last trade
14 May 2026
Last filed
15 May 2026

Companies traded

Where they are an officer
Inventiv HealthDirector, Officer · last 4 Aug 20102 buys · 9 sells
Everywhere else they filed: board seats, 10% stakes, other companies
CERT CertaraDirector, Other · Software · last 14 May 20262 buys · 0 sells
Theravance BiopharmaDirector · Pharmaceuticals · last 26 Nov 20250 buys · 3 sells
Magellan HealthDirector · last 24 May 20180 buys · 2 sells
NeurogenDirector · last 15 Dec 20090 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
14 May 2026filed 15 May 2026CERT CertaraSoftwareSEC FORM 4 Code M—15,757 at $0.00filing
14 May 2026filed 15 May 2026CERT Certaraoption or derivative · SoftwareSEC FORM 4 Code M—15,757 at $0.00filing
14 May 2026filed 15 May 2026CERT Certaraoption or derivative · SoftwareSEC FORM 4 Code A—33,222 at $0.00filing
14 May 2026filed 15 May 2026CERT Certaraoption or derivative · SoftwareSEC FORM 4 Code M—15,757 at $0.00filing
14 May 2026filed 15 May 2026CERT Certaraoption or derivative · SoftwareSEC FORM 4 Code A—33,222 at $0.00filing
14 May 2026filed 15 May 2026CERT CertaraSoftwareSEC FORM 4 Code M—15,757 at $0.00filing
26 Nov 2025filed 1 Dec 2025Theravance Biopharmaoption or derivative · PharmaceuticalsSEC FORM 4 Code M$142K14,000 at $10.15filing
26 Nov 2025filed 1 Dec 2025Theravance BiopharmaPharmaceuticalsSEC FORM 4 Sold$280K14,000 at $20.00filing
26 Nov 2025filed 1 Dec 2025Theravance BiopharmaPharmaceuticalsSEC FORM 4 Sold$310K15,501 at $20.00filing
11 Nov 2025filed 14 Nov 2025Theravance Biopharmaoption or derivative · PharmaceuticalsSEC FORM 4 Code M$142K14,000 at $10.15filing
11 Nov 2025filed 14 Nov 2025Theravance BiopharmaPharmaceuticalsSEC FORM 4 Sold$287K15,500 at $18.50filing
11 Nov 2025filed 14 Nov 2025Theravance BiopharmaPharmaceuticalsSEC FORM 4 Sold$264K15,500 at $17.00filing
11 Nov 2025filed 14 Nov 2025Theravance BiopharmaPharmaceuticalsSEC FORM 4 Sold$259K14,000 at $18.50filing
11 Nov 2025filed 13 Nov 2025Theravance Biopharmaoption or derivative · PharmaceuticalsSEC FORM 4 Code M$142K14,000 at $10.15filing
11 Nov 2025filed 13 Nov 2025Theravance BiopharmaPharmaceuticalsSEC FORM 4 Sold$546K29,500 at $18.50filing
11 Nov 2025filed 13 Nov 2025Theravance BiopharmaPharmaceuticalsSEC FORM 4 Sold$264K15,500 at $17.00filing
11 Nov 2025filed 13 Nov 2025Theravance BiopharmaPharmaceuticalsSEC FORM 4 Sold$259K14,000 at $18.50filing
21 May 2025filed 22 May 2025CERT Certaraoption or derivative · SoftwareSEC FORM 4 Code M—11,928 at $0.00filing
21 May 2025filed 22 May 2025CERT Certaraoption or derivative · SoftwareSEC FORM 4 Code A—15,757 at $0.00filing
21 May 2025filed 22 May 2025CERT CertaraSoftwareSEC FORM 4 Code M—11,928 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care3
Technology2
Not placed13

Buys in green, sells in red, by the company’s sector.

Related people

Donald J. TrumpPresident · Also traded CERT in the last 90 days